219 related articles for article (PubMed ID: 26453534)
1. Tomotherapy PET-guided dose escalation: A dosimetric feasibility study for patients with malignant pleural mesothelioma.
Maggio A; Cutaia C; Di Dia A; Bresciani S; Miranti A; Poli M; Del Mastro E; Garibaldi E; Gabriele P; Stasi M
Strahlenther Onkol; 2016 Feb; 192(2):102-8. PubMed ID: 26453534
[TBL] [Abstract][Full Text] [Related]
2. PET-guided dose escalation tomotherapy in malignant pleural mesothelioma.
Fodor A; Fiorino C; Dell'Oca I; Broggi S; Pasetti M; Cattaneo GM; Gianolli L; Calandrino R; Di Muzio NG
Strahlenther Onkol; 2011 Nov; 187(11):736-43. PubMed ID: 22037650
[TBL] [Abstract][Full Text] [Related]
3. Does selective pleural irradiation of malignant pleural mesothelioma allow radiation dose escalation? : A planning study.
Botticella A; Defraene G; Nackaerts K; Deroose C; Coolen J; Nafteux P; Vanstraelen B; Joosten S; Michiels LAW; Peeters S; De Ruysscher D
Strahlenther Onkol; 2017 Apr; 193(4):285-294. PubMed ID: 28197653
[TBL] [Abstract][Full Text] [Related]
4. Erratum to: Tomotherapy PET-guided dose escalation--A dosimetric feasibility study for patients with malignant pleural mesothelioma.
Maggio A; Cutaia C; Di Dia A; Bresciani S; Miranti A; Poli M; Delmastro E; Garibaldi E; Gabriele P; Stasi M
Strahlenther Onkol; 2015 Dec; 191(12):987. PubMed ID: 26545763
[TBL] [Abstract][Full Text] [Related]
5. Dosimetric Comparison of Lung-Sparing Radiation Therapy between Volumetric Arc Therapy and Helical Tomotherapy for Unresectable Malignant Pleural Mesothelioma.
Pehlivan B; Sengul K; Yesil A; Nalbant N; Ozturk O; Ozdemir Y; Topkan E
Biomed Res Int; 2019; 2019():4568958. PubMed ID: 31930123
[TBL] [Abstract][Full Text] [Related]
6. Heart Dosimetry is Correlated With Risk of Radiation Pneumonitis After Lung-Sparing Hemithoracic Pleural Intensity Modulated Radiation Therapy for Malignant Pleural Mesothelioma.
Yorke ED; Jackson A; Kuo LC; Ojo A; Panchoo K; Adusumilli P; Zauderer MG; Rusch VW; Shepherd A; Rimner A
Int J Radiat Oncol Biol Phys; 2017 Sep; 99(1):61-69. PubMed ID: 28816162
[TBL] [Abstract][Full Text] [Related]
7. Effect of increasing experience on dosimetric and clinical outcomes in the management of malignant pleural mesothelioma with intensity-modulated radiation therapy.
Patel PR; Yoo S; Broadwater G; Marks LB; Miles EF; D'Amico TA; Harpole D; Kelsey CR
Int J Radiat Oncol Biol Phys; 2012 May; 83(1):362-8. PubMed ID: 22516382
[TBL] [Abstract][Full Text] [Related]
8. Significant improvement in normal tissue sparing and target coverage for head and neck cancer by means of helical tomotherapy.
Fiorino C; Dell'Oca I; Pierelli A; Broggi S; De Martin E; Di Muzio N; Longobardi B; Fazio F; Calandrino R
Radiother Oncol; 2006 Mar; 78(3):276-82. PubMed ID: 16546279
[TBL] [Abstract][Full Text] [Related]
9. Dosimetric evaluation of helical tomotherapy and volumetric-modulated arc therapy for malignant pleural mesothelioma: a planning study for dose escalation.
Zhang FL; Lu N; Jiang HY; Chen DD; Wang YD
Transl Cancer Res; 2021 Feb; 10(2):914-922. PubMed ID: 35116420
[TBL] [Abstract][Full Text] [Related]
10. Tomotherapy after pleurectomy/decortication or biopsy for malignant pleural mesothelioma allows the delivery of high dose of radiation in patients with intact lung.
Minatel E; Trovo M; Polesel J; Rumeileh IA; Baresic T; Bearz A; Del Conte A; Franchin G; Gobitti C; Drigo A; Dassie A; Pagan V; Trovo MG
J Thorac Oncol; 2012 Dec; 7(12):1862-1866. PubMed ID: 23154558
[TBL] [Abstract][Full Text] [Related]
11. Moderately Hypofractionated Helical IMRT, FDG-PET/CT-guided, for Progressive Malignant Pleural Mesothelioma in Patients With Intact Lungs.
Fodor A; Broggi S; Incerti E; Dell'Oca I; Fiorino C; Samanes Gajate AM; Pasetti M; Cattaneo MG; Passoni P; Gianolli L; Calandrino R; Picchio M; Di Muzio N
Clin Lung Cancer; 2019 Jan; 20(1):e29-e38. PubMed ID: 30253920
[TBL] [Abstract][Full Text] [Related]
12. Tomotherapy in malignant mesothelioma: a planning study to establish dose constraints.
Leitzen C; Wilhelm-Buchstab T; Stumpf S; Heimann M; Koch D; Schmeel C; Simon B; Vornholt S; Garbe S; Röhner F; Schoroth F; Schild HH; Schüller H; Müdder T
Strahlenther Onkol; 2019 Jul; 195(7):668-676. PubMed ID: 30915490
[TBL] [Abstract][Full Text] [Related]
13. Additional PET/CT in week 5-6 of radiotherapy for patients with stage III non-small cell lung cancer as a means of dose escalation planning?
Gillham C; Zips D; Pönisch F; Evers C; Enghardt W; Abolmaali N; Zöphel K; Appold S; Hölscher T; Steinbach J; Kotzerke J; Herrmann T; Baumann M
Radiother Oncol; 2008 Sep; 88(3):335-41. PubMed ID: 18514339
[TBL] [Abstract][Full Text] [Related]
14. Evaluating target coverage and normal tissue sparing in the adjuvant radiotherapy of malignant pleural mesothelioma: helical tomotherapy compared with step-and-shoot IMRT.
Sterzing F; Sroka-Perez G; Schubert K; Münter MW; Thieke C; Huber P; Debus J; Herfarth KK
Radiother Oncol; 2008 Feb; 86(2):251-7. PubMed ID: 18207597
[TBL] [Abstract][Full Text] [Related]
15. Helical tomotherapy vs. intensity-modulated proton therapy for whole pelvis irradiation in high-risk prostate cancer patients: dosimetric, normal tissue complication probability, and generalized equivalent uniform dose analysis.
Widesott L; Pierelli A; Fiorino C; Lomax AJ; Amichetti M; Cozzarini C; Soukup M; Schneider R; Hug E; Di Muzio N; Calandrino R; Schwarz M
Int J Radiat Oncol Biol Phys; 2011 Aug; 80(5):1589-600. PubMed ID: 21167651
[TBL] [Abstract][Full Text] [Related]
16. Combined photon and electron three-dimensional conformal versus intensity-modulated radiotherapy with integrated boost for adjuvant treatment of malignant pleural mesothelioma after pleuropneumonectomy.
Krayenbuehl J; Oertel S; Davis JB; Ciernik IF
Int J Radiat Oncol Biol Phys; 2007 Dec; 69(5):1593-9. PubMed ID: 17931793
[TBL] [Abstract][Full Text] [Related]
17. Dosimetric Comparison Between Helical Tomotherapy and Volumetric Modulated Arc Therapy in Patients With Malignant Pleural Mesothelioma.
Müdder T; Sarria GR; Henkenberens C; Holz J; Garbe S; Röhner F; Stumpf S; Buchstab T; Giordano FA; Leitzen C
Clin Oncol (R Coll Radiol); 2022 Mar; 34(3):164-171. PubMed ID: 34429236
[TBL] [Abstract][Full Text] [Related]
18. Intensity-modulated proton therapy versus helical tomotherapy in nasopharynx cancer: planning comparison and NTCP evaluation.
Widesott L; Pierelli A; Fiorino C; Dell'oca I; Broggi S; Cattaneo GM; Di Muzio N; Fazio F; Calandrino R; Schwarz M
Int J Radiat Oncol Biol Phys; 2008 Oct; 72(2):589-96. PubMed ID: 18793962
[TBL] [Abstract][Full Text] [Related]
19. Proton therapy for malignant pleural mesothelioma after extrapleural pleuropneumonectomy.
Krayenbuehl J; Hartmann M; Lomax AJ; Kloeck S; Hug EB; Ciernik IF
Int J Radiat Oncol Biol Phys; 2010 Oct; 78(2):628-34. PubMed ID: 20385451
[TBL] [Abstract][Full Text] [Related]
20. Hypoxia-guided adaptive radiation dose escalation in head and neck carcinoma: a planning study.
Servagi-Vernat S; Differding S; Sterpin E; Hanin FX; Labar D; Bol A; Lee JA; Grégoire V
Acta Oncol; 2015 Jul; 54(7):1008-16. PubMed ID: 25562382
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
